IVAX VERAPAMIL ER SALES ARE $145.9 MIL. IN 1993, OR 29% OF PHARMACEUTICAL NET REVENUES OF $500.5 MIL.; VALUE HEALTH 12-MONTH Rx DRUG REVENUES ARE $364.7 MIL.
Executive Summary
Ivax sales of verapamil extended-release tablets totaled $145.9 mil. in 1993 and were $50.8 mil. in the fourth quarter, the healthcare and consumer products holding company reported Feb. 28.